Sesen Bio Inc. (SESN) Shares: Are They Risky Or Cheap?

Sesen Bio Inc. (NASDAQ:SESN) finished Wednesday with an addition of $0.22 to close at $1.05, an upside of 26.90 percent. An average of 10,323,220 shares of common stock have been traded in the last five days. There was a gain of $0.3220 in the past week. The last 20 days have seen an average of 10,367,405 shares traded, while the 50-day average volume stands at 24,857,695.

SESN stock has increased by 13.76% in the last month. The company shares reached their 1-month lowest point of $0.7280 on 10/06/21. With the stock rallying to its 52-week high on 08/13/21, shares of the company touched a low of $0.70 and a high of $6.04 in 52 weeks. In spite of this, the price is down -82.62% from the 52-week high.


A Backdoor Way To Profit From Today’s Crypto Bull Market

In any crypto bull market, there's a lot of money to be made.

But what if we told you the best opportunities are not cryptocurrencies themselves… but instead, simply crypto stocks?

This strategy is simply and ridiculously easy.

Here are 6 ways to gain exposure to crypto outside the norm. This is arguably the safest bet you can make.

Sponsored


Valuation Metrics

Sesen Bio Inc. (SESN) has a trailing price-to-earnings (P/E) ratio of 34.65 for the broader industry and 32.30 for the sector. In the last five years, Sesen Bio Inc.’s PE ratio has ranged between 58.75 and 4.619. The stock’s beta is 0.41. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 11.65, the price-to-book (PB) ratio at 3.75.

The quick ratio of Sesen Bio Inc. for the three months ended June 29 was 9.30, and the current ratio was 9.30, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending June 29. Sesen Bio Inc.’s EBITDA margin for the year ending June 29 is -286.00%. Its gross profit as reported stood at $32.31 million compared to revenue of $11.24 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Sesen Bio Inc.’s return on assets was -71.90%, compared to -36.0% over the last five years. For the broader industry, ROE averaged -68.79 over the past year.

Earnings Surprise

The analyst consensus anticipated Sesen Bio Inc.’s latest quarter earnings to come in at -$0.06 per share, but it turned out to be -$0.15, a -150.00% surprise. For the quarter, EBITDA amounted to -$25.36 million. Shareholders own equity worth $196.0 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Sesen Bio Inc. (SESN) price momentum. RSI 9-day as of the close on 13 October was 71.27%, suggesting the stock is Overbought, with historical volatility in this time frame at 137.93%.

As of today, SESN’s price is $0.8184 +44.23% or $0.3220 from its 5-day moving average. SESN is currently trading +12.23% higher than its 20-day SMA and -64.53% lower than its 100-day SMA. However, the stock’s current price level is -73.68% below the SMA50 and -14.63% below the SMA200.

The stochastic %K and %D were 53.36% and 27.11%, respectively, and the average true range (ATR) was 0.0861. With the 14-day stochastic at 96.99% and the average true range at 0.1083, the RSI (14) stands at 53.86%. The stock has reached 0.0817 on the 9-day MACD Oscillator while the 14-day reading was at 0.0789.

Analyst Ratings

H.C. Wainwright downgraded Sesen Bio Inc. (NASDAQ: SESN) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as a a Buy.The consensus rating for Sesen Bio Inc. (SESN) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell SESN, while 2 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 1 others rate it as a “buy”.

What is SESN’s price target for the next 12 months?

Analysts predict a range of price targets between $1.50 and $8.00, with a median target of $3.00. Taking a look at these predictions, the average price target given by analysts for Sesen Bio Inc. (SESN) stock is $4.17.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img

Hot Topics

Related Videos

Related Videos

Related Articles

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

592

100% free. stop anytime no spam